Concepedia

Author

Francesco Parlati

Calithera (United States)ORCID

Also Known As

F Parlati, F. Parlati, Francesco Parlati, Parlati, Francesco

109

Publications

10.5K

Citations

32

H-Index

69

Concepts

All Affiliations

Calithera (United States)Memorial Sloan Kettering Cancer CenterRice UniversityThe University of Texas MD Anderson Cancer CenterThe University of Tokyo
FP

About

Francesco Parlati is an author at Calithera (United States) specializing in medicine, cell biology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

19

6.5K

2

Cell Biology

10

10

2.3K

3

Natural Sciences

7

7

3.2K

4

Cellular Physiology

6

6

1.5K

5

Biochemistry

5

5

1.4K

Francesco Parlati

×

39

Publications

10.3K

Citations

30

H-Index

YearCitations

SNAREpins: Minimal Machinery for Membrane Fusion

Thomas Weber, Boris V. Zemelman, James A. McNew,

Cell

1998

2.5K

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

Matt I. Gross, Susan D. Demo, Jennifer B. Dennison,

Molecular Cancer Therapeutics

2014

1K

Compartmental specificity of cellular membrane fusion encoded in SNARE proteins

James A. McNew, Francesco Parlati, Ryouichi Fukuda,

Nature

2000

688

Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome

Susan D. Demo, Christopher J. Kirk, Monette Aujay,

Cancer Research

2007

668

A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis

Tony Muchamuel, Michael Basler, Monette Aujay,

Nature Medicine

2009

590

Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment

Susanne Steggerda, Mark K. Bennett, Jason Chen,

Journal for ImmunoTherapy of Cancer

2017

416

Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events

Shirin Arastu‐Kapur, Janet L. Anderl, Marianne Kraus,

Clinical Cancer Research

2011

405

Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome

Francesco Parlati, Monette Aujay, Érika Suzuki,

Blood

2009

320

Close Is Not Enough

James A. McNew, Thomas Weber, Francesco Parlati,

The Journal of Cell Biology

2000

299

Topological restriction of SNARE-dependent membrane fusion

Francesco Parlati, James A. McNew, Ryouichi Fukuda,

Nature

2000

285

Page 1